1. Home
  2. PROC

PROC

Procaps Group S.A.

Logo Procaps Group S.A.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-12-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Procaps Group SA is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies. It develops, manufactures, and markets over-the-counter (OTC) and prescription drugs, nutritional supplements, and high-potency clinical solutions. The company's segment includes NextGel; Procaps Colombia; CAN; CASAND and Diabetrics. It generates maximum revenue from the Procaps Colombia segment.

Founded: 1976 Country:
Luxembourg
Luxembourg
Employees: N/A City: N/A
Market Cap: 315.9M IPO Year: N/A
Target Price: $4.50 AVG Volume (30 days): 15.8K
Analyst Decision: Hold Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: 0.52 EPS Growth: -13.33
52 Week Low/High: $1.95 - $5.38 Next Earning Date: 06-03-2024
Revenue: $414,096,000 Revenue Growth: -4.80%
Revenue Growth (this year): 5.54% Revenue Growth (next year): 8.54%

Share on Social Networks: